-
A649748-1mgAbemaciclib-d 8 is the deuterium labeled Abemaciclib. Abemaciclib (LY2835219) is a selective CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6 , respectively.In VitroStable heavy isotopes of hydrogen, carbon, and other elements
-
A649748-5mgAbemaciclib-d 8 is the deuterium labeled Abemaciclib. Abemaciclib (LY2835219) is a selective CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6 , respectively.In VitroStable heavy isotopes of hydrogen, carbon, and other elements
-
A648041-10mgAbeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H + , K + - ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump
-
A648041-5mgAbeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H + , K + - ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump
-
A655268-1mlAbeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H + , K + - ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump
-
A646733-10mgAbeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H + , K + - ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride
-
A646733-5mgAbeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H + , K + - ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride
-
A649778-10mgAbiraterone sulfate is a metabolite of Abiraterone ( HY-148377 ). Abiraterone is a potent and irreversible CYP17A1 inhibitor with antiandrogen activity.Form:Solid.
-
A649778-1mgAbiraterone sulfate is a metabolite of Abiraterone ( HY-148377 ). Abiraterone is a potent and irreversible CYP17A1 inhibitor with antiandrogen activity.Form:Solid.
-
A649778-5mgAbiraterone sulfate is a metabolite of Abiraterone ( HY-148377 ). Abiraterone is a potent and irreversible CYP17A1 inhibitor with antiandrogen activity.Form:Solid.
-
A650635-10mgAblukast (Ro 23-3544) is a specific and active leukotriene receptor antagonist. Ablukast effectively reduces LTC4- and antigen-induced bronchoconstriction. Ablukast is LTD4 receptor antagonist .In VitroAblukast (Ro 23-3544) is tested for its
-
A650635-1mgAblukast (Ro 23-3544) is a specific and active leukotriene receptor antagonist. Ablukast effectively reduces LTC4- and antigen-induced bronchoconstriction. Ablukast is LTD4 receptor antagonist .In VitroAblukast (Ro 23-3544) is tested for its